Talk to a public procurement expert
company logo

Licitaciones a Incyte Biosciences Iberia, S.L

Detailed analysis of Incyte Biosciences Iberia, S.L as an awardee: Over the last 6 months it has participated in 104 public procurement procedures, with a success rate of 100%. The average budget of won tenders amounts to 59.923,53 €, with an average discount of 0.00%. The total volume awarded reaches 4.614.408,99 €, distributed among 18 contracting entities. Its main sector is Equipamiento y artículos médicos, farmacéuticos y de higiene personal, representing 70% of its awards. The entity that has awarded it the most contracts is SERVICIO ANDALUZ DE SALUD, with 60 awards.

Tenders

104
Awarded: 104
In progress: 0
Unawarded: 0

Budgets

4.494.265 €
Awarded amount: 4.494.265 €
Minor contracts: 414.594 €
Estimated value: 6.958.864 €

Averages

59.924 €
Discount rate: 0%
Number of bidders: 1,0
Number of lots: 0

Organizations

18
Successful bidders: 1
Minor contracts: 94

Top 5 Budgets

CONTRACT OBJECTBASE BUDGETDETAILS

Suministro de Ponatinib (DOE)...

1.278.720 € View more

Suministro de Ponatinib (DOE)...

1.278.720 € View more

Suministro de Ruxolitinib fosfato (DOE) crema...

1.132.200 € View more

Suministro del medicamento cuyo Principio Activo es PONATINIB para el Complejo A...

181.152 € View more

P.N.S.P. 20/2025. Suministro del medicamento exclusivo: Ruxolitinib (OPZELURA)...

112.387,5 € View more

Latest tenders won by Incyte Biosciences Iberia, S.L - Diciembre 2025

Be the first to know about all tenders to Incyte Biosciences Iberia, S.L in the last 12 months.

CONTRACT OBJECTBASE BUDGETFILE NUMBERDETAILS

RUXOLITINIB 15MG/G, G CREMA

⏱️ Offer submission deadline: 9 dic 18:47

6243,75 € CONTR20250000488632View more

PONATINIB 30MG, COMPRIMIDOS

⏱️ Offer submission deadline: 9 dic 14:45

5328 € CONTR20250000478505View more

TAFASITAMAB 200MG/INYECTABLE IV

⏱️ Offer submission deadline: 5 dic 01:51

8680 € CONTR20250000600733View more

TAFASITAMAB 200MG/INYECTABLE IV

⏱️ Offer submission deadline: 5 dic 00:26

6510 € CONTR20250000582547View more

TAFASITAMAB 200MG/INYECTABLE IV

⏱️ Offer submission deadline: 5 dic 00:03

6510 € CONTR20250000582589View more

Explore More Related Content

🏛️

Contracting Organizations

Discover the public organizations this company has worked with and their main contracts.

View organizations
📍

Tenders by Location

Explore the tenders available in Spain where this company could participate.

View tenders in Spain
🏢

Specialization Sectors

Learn about the sectors where this company has more experience and success in tenders.

Explore sectors
📋

Frequent CPV Codes

Review the most used CPV codes in the tenders this company has won.

View CPV codes
⚔️

Direct Competition

Analyze other bidding companies in the same sector to understand the competitive landscape.

View competition
📈

Market Trends

Stay up to date with the latest trends in public procurement and emerging opportunities.

View trends